85 related articles for article (PubMed ID: 8088601)
21. Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.
Sherman ME; Sturgeon S; Brinton LA; Potischman N; Kurman RJ; Berman ML; Mortel R; Twiggs LB; Barrett RJ; Wilbanks GD
Mod Pathol; 1997 Oct; 10(10):963-8. PubMed ID: 9346174
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous metastasis of papillary serous uterine cancer.
Elit L; Lukka H; Friedman E
Gynecol Oncol; 2001 Jul; 82(1):208-11. PubMed ID: 11426989
[TBL] [Abstract][Full Text] [Related]
23. What staging surgery should be performed on patients with uterine papillary serous carcinoma?
Geisler JP; Geisler HE; Melton ME; Wiemann MC
Gynecol Oncol; 1999 Sep; 74(3):465-7. PubMed ID: 10479511
[TBL] [Abstract][Full Text] [Related]
24. [Uterine papillary serous carcinoma--one kind of special type of uterine endometrial carcinoma].
Wu M; Lang J; Guo L
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):3-7. PubMed ID: 8758809
[TBL] [Abstract][Full Text] [Related]
25. Role of cytoreduction in stage III and IV uterine papillary serous carcinoma.
Thomas MB; Mariani A; Cliby WA; Keeney GL; Podratz KC; Dowdy SC
Gynecol Oncol; 2007 Nov; 107(2):190-3. PubMed ID: 17825394
[TBL] [Abstract][Full Text] [Related]
26. Uterine papillary serous carcinomas: the exigency for clinical trials.
Podratz KC; Mariani A
Gynecol Oncol; 2003 Dec; 91(3):461-2. PubMed ID: 14675662
[No Abstract] [Full Text] [Related]
27. Papillary serous carcinoma of the uterus: increased risk of subsequent or concurrent development of breast carcinoma.
Geisler JP; Sorosky JI; Duong HL; Buekers TE; Geisler MJ; Sood AK; Anderson B; Buller RE
Gynecol Oncol; 2001 Dec; 83(3):501-3. PubMed ID: 11733962
[TBL] [Abstract][Full Text] [Related]
28. Familial papillary serous carcinoma of the cervix, peritoneum, and ovary: a report of the first case.
Kaplan EJ; Caputo TA; Shen PU; Sassoon RI; Soslow RA
Gynecol Oncol; 1998 Aug; 70(2):289-94. PubMed ID: 9740708
[TBL] [Abstract][Full Text] [Related]
29. p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma.
Bancher-Todesca D; Gitsch G; Williams KE; Kohlberger P; Neunteufel W; Obermair A; Heinze G; Breitenecker G; Hacker NF
Gynecol Oncol; 1998 Oct; 71(1):59-63. PubMed ID: 9784320
[TBL] [Abstract][Full Text] [Related]
30. Amplification of c-erbB2 oncogene: a major prognostic indicator in uterine serous papillary carcinoma.
Santin AD; Bellone S; Van Stedum S; Bushen W; Palmieri M; Siegel ER; De Las Casas LE; Roman JJ; Burnett A; Pecorelli S
Cancer; 2005 Oct; 104(7):1391-7. PubMed ID: 16116605
[TBL] [Abstract][Full Text] [Related]
31. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients.
Grice J; Ek M; Greer B; Koh WJ; Muntz HG; Cain J; Tamimi H; Stelzer K; Figge D; Goff BA
Gynecol Oncol; 1998 Apr; 69(1):69-73. PubMed ID: 9571001
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy in uterine papillary serous carcinoma.
Resnik E; Taxy JB
Gynecol Oncol; 1996 Jul; 62(1):123-7. PubMed ID: 8690284
[TBL] [Abstract][Full Text] [Related]
33. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
[TBL] [Abstract][Full Text] [Related]
34. Combined ovarian serous papillary and hepatoid carcinoma.
Scurry JP; Brown RW; Jobling T
Gynecol Oncol; 1996 Oct; 63(1):138-42. PubMed ID: 8898184
[TBL] [Abstract][Full Text] [Related]
35. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
Sun X; Shi S; Sheng X
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
[TBL] [Abstract][Full Text] [Related]
36. The use of paclitaxel and platinum-based chemotherapy in uterine papillary serous carcinoma.
Zanotti KM; Belinson JL; Kennedy AW; Webster KD; Markman M
Gynecol Oncol; 1999 Aug; 74(2):272-7. PubMed ID: 10419744
[TBL] [Abstract][Full Text] [Related]
37. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
Bristow RE; Asrari F; Trimble EL; Montz FJ
Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
[TBL] [Abstract][Full Text] [Related]
38. Establishment and characterization of a human cell line derived from a uterine papillary serous carcinoma with wild-type p53 function.
Hashimoto H; Kojima A; Sudo T; Ohki N; Yamaguchi S; Mikami Y; Ito M; Nishimura R
Hum Cell; 2008 Aug; 21(3):64-9. PubMed ID: 18667022
[TBL] [Abstract][Full Text] [Related]
39. Uterine papillary serous carcinoma: patterns of failure and survival.
Wang W; DO V; Hogg R; Wain G; Brand A; Bull C; Stenlake A; Gebski V
Aust N Z J Obstet Gynaecol; 2009 Aug; 49(4):419-25. PubMed ID: 19694700
[TBL] [Abstract][Full Text] [Related]
40. The role of abdominal-pelvic radiotherapy in the management of uterine papillary serous carcinoma.
Kwon J; Ackerman I; Franssen E
Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1439-45. PubMed ID: 15275730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
